Michael A. Sheard

2.5k total citations
51 papers, 2.1k citations indexed

About

Michael A. Sheard is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Michael A. Sheard has authored 51 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Immunology and 19 papers in Oncology. Recurrent topics in Michael A. Sheard's work include Neuroblastoma Research and Treatments (18 papers), Immune Cell Function and Interaction (14 papers) and Cell death mechanisms and regulation (9 papers). Michael A. Sheard is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), Immune Cell Function and Interaction (14 papers) and Cell death mechanisms and regulation (9 papers). Michael A. Sheard collaborates with scholars based in United States, Czechia and United Kingdom. Michael A. Sheard's co-authors include Robert C. Seeger, Richard Sposto, Megan Sykes, David H. Sachs, R. Xiong, G. Xie, Bořivoj Vojtěšek, Jemily Malvar, Shahab Asgharzadeh and Jan Žaloudík and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Michael A. Sheard

51 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Sheard United States 27 796 747 741 374 298 51 2.1k
Masaki Inoue Japan 27 326 0.4× 503 0.7× 934 1.3× 89 0.2× 301 1.0× 91 2.4k
Y Niitsu Japan 21 376 0.5× 508 0.7× 1.1k 1.4× 46 0.1× 235 0.8× 79 2.4k
Qingming Yang China 20 704 0.9× 2.4k 3.2× 715 1.0× 97 0.3× 95 0.3× 62 2.9k
A F Gazdar United States 16 302 0.4× 573 0.8× 707 1.0× 279 0.7× 186 0.6× 20 1.6k
Daniel Wicklein Germany 24 285 0.4× 521 0.7× 766 1.0× 34 0.1× 363 1.2× 60 1.6k
Enrico Fontanella Italy 26 331 0.4× 1.1k 1.5× 1.8k 2.4× 22 0.1× 461 1.5× 40 2.6k
Rei Takahashi Japan 23 113 0.1× 794 1.1× 1.1k 1.4× 55 0.1× 440 1.5× 62 2.1k
Wendy Halpern United States 16 472 0.6× 353 0.5× 848 1.1× 42 0.1× 181 0.6× 42 1.5k
Congcong Zhang China 25 1.1k 1.4× 1.4k 1.9× 1.1k 1.5× 37 0.1× 469 1.6× 78 2.8k
Guillaume Meurice France 17 535 0.7× 552 0.7× 732 1.0× 25 0.1× 318 1.1× 34 1.7k

Countries citing papers authored by Michael A. Sheard

Since Specialization
Citations

This map shows the geographic impact of Michael A. Sheard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Sheard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Sheard more than expected).

Fields of papers citing papers by Michael A. Sheard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Sheard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Sheard. The network helps show where Michael A. Sheard may publish in the future.

Co-authorship network of co-authors of Michael A. Sheard

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Sheard. A scholar is included among the top collaborators of Michael A. Sheard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Sheard. Michael A. Sheard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zobel, Michael J., Hongwei Wu, Jianping Sun, et al.. (2020). Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice. Journal for ImmunoTherapy of Cancer. 8(2). e001560–e001560. 13 indexed citations
2.
Wu, Hongwei, Michael A. Sheard, Jemily Malvar, et al.. (2019). Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells. Clinical Cancer Research. 25(15). 4761–4774. 57 indexed citations
3.
4.
Jackson, Jeremy R., Grace E. Asuelime, Hongwei Wu, et al.. (2018). Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma. Clinical Cancer Research. 25(1). 325–333. 48 indexed citations
5.
Borriello, Lucia, Rie Nakata, Michael A. Sheard, et al.. (2017). Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells. Cancer Research. 77(18). 5142–5157. 146 indexed citations
6.
Tran, Hung C., Zesheng Wan, Michael A. Sheard, et al.. (2016). TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells. Clinical Cancer Research. 23(3). 804–813. 106 indexed citations
7.
Ara, Tasnim, Rie Nakata, Michael A. Sheard, et al.. (2013). Critical Role of STAT3 in IL-6–Mediated Drug Resistance in Human Neuroblastoma. Cancer Research. 73(13). 3852–3864. 105 indexed citations
8.
Liu, Yin, Michael A. Sheard, Richard Sposto, et al.. (2013). Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy. Clinical Cancer Research. 19(8). 2132–2143. 85 indexed citations
9.
Xu, Yibing, Jianping Sun, Michael A. Sheard, et al.. (2013). Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1. Cancer Immunology Immunotherapy. 62(10). 1637–1648. 58 indexed citations
10.
Chi, Feng, Lin Wang, Chunhua Wu, et al.. (2011). Meningitic Escherichia coli K1 Penetration and Neutrophil Transmigration Across the Blood–Brain Barrier are Modulated by Alpha7 Nicotinic Receptor. PLoS ONE. 6(9). e25016–e25016. 30 indexed citations
11.
Dubská, Lenka Zdražilová, Ladislav Anděra, & Michael A. Sheard. (2005). HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: An unexpected effect on TRAIL‐induced apoptosis. FEBS Letters. 579(19). 4149–4158. 38 indexed citations
12.
Sheard, Michael A., Cunlan Liu, & Yousuke Takahama. (2003). Developmental status of CD4–CD8+ and CD4+CD8– thymocytes with medium expression of CD3. European Journal of Immunology. 34(1). 25–35. 2 indexed citations
13.
Sheard, Michael A., et al.. (2002). Release of cytokeratin‐18 and ‐19 fragments (TPS and CYFRA 21‐1) into the extracellular space during apoptosis. Journal of Cellular Biochemistry. 85(4). 670–677. 81 indexed citations
14.
Sheard, Michael A.. (2001). Ionizing radiation as a response‐enhancing agent for CD95‐mediated apoptosis. International Journal of Cancer. 96(4). 213–220. 33 indexed citations
15.
Sheard, Michael A., Susan O. Sharrow, & Yousuke Takahama. (2000). Synchronous Deletion of Mtv-Superantigen-Reactive Thymocytes in the CD3medium/high CD4+CD8+ Subset. Scandinavian Journal of Immunology. 52(6). 550–554. 3 indexed citations
16.
Sheard, Michael A., et al.. (1997). Up-regulation of Fas (CD95) in human p53wild-type cancer cells treated with ionizing radiation. International Journal of Cancer. 73(5). 757–762. 106 indexed citations
17.
Žaloudík, Jan, et al.. (1997). Biomarkers for predicting response to regional chemoimmunotherapy in liver metastases from colorectal carcinoma. International Journal of Immunopharmacology. 19(9-10). 481–485. 8 indexed citations
18.
19.
Sykes, Megan, Michael A. Sheard, & David H. Sachs. (1988). Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells.. The Journal of Experimental Medicine. 168(6). 2391–2396. 96 indexed citations
20.
Sykes, Megan, Michael A. Sheard, & David H. Sachs. (1988). Effects of T cell depletion in radiation bone marrow chimeras. II. Requirement for allogeneic T cells in the reconstituting bone marrow inoculum for subsequent resistance to breaking of tolerance.. The Journal of Experimental Medicine. 168(2). 661–673. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaki Inoue Breakdown of academic impact, for papers by Y Niitsu Breakdown of academic impact, for papers by Qingming Yang Breakdown of academic impact, for papers by A F Gazdar Breakdown of academic impact, for papers by Daniel Wicklein Breakdown of academic impact, for papers by Enrico Fontanella Breakdown of academic impact, for papers by Rei Takahashi Breakdown of academic impact, for papers by Wendy Halpern Breakdown of academic impact, for papers by Congcong Zhang Breakdown of academic impact, for papers by Guillaume Meurice
Rankless by CCL
2026